CTLA4 and cancer: Similarly, Bacteroides thetaiotamicron and nontoxigenic B. fragilis improve the efficacy of an anti–cytotoxic T-lymphocyte-associated protein 4 (CTLA4) immunotherapeutic tested in 3 cancer xenograft mouse models.